Literature DB >> 9708759

Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients.

S Neugebauer, T Baba, T Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9708759     DOI： 10.1016/S0140-6736(05)79188-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Katrin Uhlig; George N Koukoulis; Afroditi A Papathanasiou; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

2.  MTHFR gene C677T polymorphism and type 2 diabetic nephropathy in Asian populations: a meta-analysis.

Authors:  Haiyan Chen; Fang Wei; Lihua Wang; Zhe Wang; Jia Meng; Lan Jia; Guijiang Sun; Ruining Zhang; Bo Li; Haibo Yu; Haiyan Pang; Xueqing Bi; Hongye Dong; Aili Jiang; Lin Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors:  Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

4.  Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy.

Authors:  Kubilay Ukinc; Halil Onder Ersoz; Caner Karahan; Cihangir Erem; Selcuk Eminagaoglu; Arif Bayram Hacihasanoglu; Mustafa Yilmaz; Mustafa Kocak
Journal:  Endocrine       Date:  2009-07-14       Impact factor: 3.633

5.  Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease.

Authors:  Gabriele Stocco; Stefano Martelossi; Franca Sartor; Giuseppe Toffoli; Paolo Lionetti; Arrigo Barabino; Massimo Fontana; Giuliana Decorti; Fiora Bartoli; Tullio Giraldi; Alessandro Ventura
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

6.  Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study.

Authors:  Franziska Marti; Peter Vollenweider; Pedro-Manuel Marques-Vidal; Vincent Mooser; Gérard Waeber; Fred Paccaud; Murielle Bochud
Journal:  BMC Public Health       Date:  2011-09-26       Impact factor: 3.295

7.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

8.  Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53.

Authors:  David L Duffy; Stephen P McDonald; Beverley Hayhurst; Sianna Panagiotopoulos; Trudy J Smith; Xing L Wang; David E Wilcken; Natalia L Duarte; John Mathews; Wendy E Hoy
Journal:  BMC Nephrol       Date:  2016-11-21       Impact factor: 2.388

9.  Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.

Authors:  Yanzi Meng; Xiaoling Liu; Kai Ma; Lili Zhang; Mao Lu; Minsu Zhao; Min-Xin Guan; Guijun Qin
Journal:  Mol Genet Genomic Med       Date:  2019-10-30       Impact factor: 2.183

10.  Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.

Authors:  Hui Guan; Meng-Di Xia; Miao Wang; Ying-Jie Guan; Xiao-Chen Lyu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.